Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX(R) (varenicline) Tablets Due to N- Nitroso Varenicline Content

NEW YORK, NY, Sept 19, 2021 -- Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable D... Biopharmaceuticals, FDA, Product Recall Pfizer, CHANTIX, varenicline
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news